IL94052A - Pharmaceutical preparations containing cytokines for the treatment of pre-neoplastic lesions and the use of the above cytokines - Google Patents
Pharmaceutical preparations containing cytokines for the treatment of pre-neoplastic lesions and the use of the above cytokinesInfo
- Publication number
- IL94052A IL94052A IL9405290A IL9405290A IL94052A IL 94052 A IL94052 A IL 94052A IL 9405290 A IL9405290 A IL 9405290A IL 9405290 A IL9405290 A IL 9405290A IL 94052 A IL94052 A IL 94052A
- Authority
- IL
- Israel
- Prior art keywords
- cytokines
- cytokine
- combination
- treatment
- preneoplastic lesions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3911720 | 1989-04-11 | ||
DE4005416 | 1990-02-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL94052A0 IL94052A0 (en) | 1991-01-31 |
IL94052A true IL94052A (en) | 1995-06-29 |
Family
ID=25879777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9405290A IL94052A (en) | 1989-04-11 | 1990-04-09 | Pharmaceutical preparations containing cytokines for the treatment of pre-neoplastic lesions and the use of the above cytokines |
Country Status (14)
Country | Link |
---|---|
US (1) | US5128126A (zh) |
EP (1) | EP0392300B1 (zh) |
JP (1) | JPH02304027A (zh) |
KR (1) | KR900015754A (zh) |
AT (1) | ATE79763T1 (zh) |
AU (1) | AU638982B2 (zh) |
CA (1) | CA2014130A1 (zh) |
DE (1) | DE59000270D1 (zh) |
DK (1) | DK0392300T3 (zh) |
ES (1) | ES2034790T3 (zh) |
GR (1) | GR3005528T3 (zh) |
HU (1) | HU206834B (zh) |
IE (1) | IE64765B1 (zh) |
IL (1) | IL94052A (zh) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6605712B1 (en) * | 1990-12-20 | 2003-08-12 | Arch Development Corporation | Gene transcription and ionizing radiation: methods and compositions |
WO1993011769A1 (en) * | 1991-12-10 | 1993-06-24 | Otsuka Pharmaceutical Co., Ltd | Carcinostatic |
FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
US5571797A (en) * | 1994-05-11 | 1996-11-05 | Arch Development Corporation | Method of inducing gene expression by ionizing radiation |
US6719977B1 (en) * | 1998-02-12 | 2004-04-13 | The General Hospital Corporation | Methods to potentiate cancer therapies |
WO1999040929A1 (en) * | 1998-02-12 | 1999-08-19 | The General Hospital Corporation | Methods to potentiate cancer therapies |
EP1278544A4 (en) * | 2000-04-12 | 2004-08-18 | Human Genome Sciences Inc | ALBUMIN FUSION PROTEINS |
US20050084478A1 (en) * | 2000-10-17 | 2005-04-21 | Chih-Ping Liu | Combination therapy using interferon-tau |
US20050118138A1 (en) * | 2000-07-19 | 2005-06-02 | Chih-Ping Liu | Method of treatment using interferon-tau |
US20040247565A1 (en) * | 2000-07-19 | 2004-12-09 | Chih-Ping Liu | Method of treatment using interferon-tau |
US20050118137A1 (en) * | 2000-07-19 | 2005-06-02 | Chih-Ping Liu | Method of treatment using interferon-tau |
US20050226845A1 (en) * | 2004-03-10 | 2005-10-13 | Chih-Ping Liu | Method of treatment using interferon-tau |
US20050201981A1 (en) * | 2004-03-10 | 2005-09-15 | Chih-Ping Liu | Method of optimizing treatment with interferon-tau |
US7431920B2 (en) * | 2000-07-19 | 2008-10-07 | Pepgen Corporation | Method of treating IL-10 deficiency |
US20020150541A1 (en) * | 2000-09-12 | 2002-10-17 | Gene Trol Biotherapeutics, Inc. | Compositions comprising mixtures of therapeutic proteins and methods of producing the same |
EP1318834A2 (en) * | 2000-09-12 | 2003-06-18 | Genetrol Biotherapeutics, Inc. | Compositions comprising mixtures of human cytokines and methods of producing the same |
US20030129162A1 (en) * | 2000-09-12 | 2003-07-10 | Lau Allan S. | Compositions comprising mixtures of therapeutic proteins and methods of producing the same |
WO2002080849A2 (en) * | 2001-04-06 | 2002-10-17 | University Of Chicago | Chemotherapeutic induction of egr-1 promoter activity |
US20040242523A1 (en) * | 2003-03-06 | 2004-12-02 | Ana-Farber Cancer Institue And The Univiersity Of Chicago | Chemo-inducible cancer gene therapy |
US8034791B2 (en) | 2001-04-06 | 2011-10-11 | The University Of Chicago | Activation of Egr-1 promoter by DNA damaging chemotherapeutics |
EP1401477A4 (en) * | 2001-05-25 | 2005-02-02 | Human Genome Sciences | CHIMIOKINE BETA-1 HYBRID PROTEINS |
KR101271635B1 (ko) * | 2001-12-21 | 2013-06-12 | 휴먼 게놈 사이언시즈, 인코포레이티드 | 알부민 융합 단백질 |
WO2005003296A2 (en) | 2003-01-22 | 2005-01-13 | Human Genome Sciences, Inc. | Albumin fusion proteins |
EP2277910A1 (en) | 2001-12-21 | 2011-01-26 | Human Genome Sciences, Inc. | Albumin fusion proteins |
WO2005046746A2 (en) * | 2003-11-10 | 2005-05-26 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
US20060078942A1 (en) * | 2004-03-10 | 2006-04-13 | Pepgen Corporation | Method of treatment using interferon-tau |
US20080025948A1 (en) * | 2004-03-10 | 2008-01-31 | Chih-Ping Liu | Methods of Treatment Using Interferon-Tau |
US20070212298A1 (en) * | 2004-08-25 | 2007-09-13 | Prefix Suffix | Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma |
US20080241100A1 (en) * | 2007-03-27 | 2008-10-02 | Stefan Strobl | Pharmaceutical composition comprising a cytokine |
CA2682050A1 (en) * | 2007-03-27 | 2008-10-02 | 4Sc Ag | Pharmaceutical composition comprising a cytokine |
EP1977759A1 (en) * | 2007-03-27 | 2008-10-08 | 4Sc Ag | Pharmaceutical composition comprising a cytokine |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983001198A1 (en) * | 1981-10-08 | 1983-04-14 | Kurt Frimann Berg | Method and composition for treating a patient suffering from interferon-susceptible disorder |
AU9051882A (en) * | 1981-10-08 | 1983-04-27 | Berg, Kurt Frimann | Method and composition for treating a patient suffering from interferon-susceptible disorders |
US4507281A (en) * | 1981-10-13 | 1985-03-26 | Exovir, Inc. | Interferon-containing compositions |
DE3278234D1 (en) * | 1981-10-13 | 1988-04-21 | Exovir Inc | Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis |
DE3423234A1 (de) * | 1984-06-23 | 1986-02-06 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Synergistische mischungen von interferonen und tumor-nekrose-faktor |
US4605555A (en) * | 1984-09-20 | 1986-08-12 | Sun Star Kabushiki Kaisha | Composition and method for treating keratosic disorder of skin and mucosa |
US4822605A (en) * | 1986-02-18 | 1989-04-18 | Exovir, Inc. | Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
-
1990
- 1990-03-31 ES ES199090106221T patent/ES2034790T3/es not_active Expired - Lifetime
- 1990-03-31 DK DK90106221.6T patent/DK0392300T3/da active
- 1990-03-31 EP EP90106221A patent/EP0392300B1/de not_active Expired - Lifetime
- 1990-03-31 DE DE9090106221T patent/DE59000270D1/de not_active Expired - Fee Related
- 1990-03-31 AT AT90106221T patent/ATE79763T1/de not_active IP Right Cessation
- 1990-04-09 IL IL9405290A patent/IL94052A/en not_active IP Right Cessation
- 1990-04-09 US US07/505,269 patent/US5128126A/en not_active Expired - Fee Related
- 1990-04-09 CA CA002014130A patent/CA2014130A1/en not_active Abandoned
- 1990-04-10 AU AU53105/90A patent/AU638982B2/en not_active Ceased
- 1990-04-10 HU HU902145A patent/HU206834B/hu not_active IP Right Cessation
- 1990-04-10 IE IE129790A patent/IE64765B1/en not_active IP Right Cessation
- 1990-04-10 JP JP2094884A patent/JPH02304027A/ja active Pending
- 1990-04-11 KR KR1019900004955A patent/KR900015754A/ko not_active Application Discontinuation
-
1992
- 1992-08-27 GR GR920401805T patent/GR3005528T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
HU902145D0 (en) | 1990-07-28 |
ATE79763T1 (de) | 1992-09-15 |
KR900015754A (ko) | 1990-11-10 |
ES2034790T3 (es) | 1993-04-01 |
HUT54303A (en) | 1991-02-28 |
IL94052A0 (en) | 1991-01-31 |
CA2014130A1 (en) | 1990-10-11 |
DE59000270D1 (de) | 1992-10-01 |
JPH02304027A (ja) | 1990-12-17 |
EP0392300A1 (de) | 1990-10-17 |
DK0392300T3 (da) | 1992-09-28 |
AU638982B2 (en) | 1993-07-15 |
HU206834B (en) | 1993-01-28 |
AU5310590A (en) | 1990-10-18 |
GR3005528T3 (zh) | 1993-06-07 |
US5128126A (en) | 1992-07-07 |
IE64765B1 (en) | 1995-09-06 |
IE901297L (en) | 1990-10-11 |
EP0392300B1 (de) | 1992-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5128126A (en) | Use of pharmaceutical compositions containing at least one cytokine for the systemic treatment of preneoplastic lesions | |
US4791101A (en) | Synergistic mixtures of interferons and tumor necrosis factor | |
RU2128056C1 (ru) | Способы и препараты для лечения заболеваний интерфероном, характеризующиеся сниженными побочными эффектами | |
EP0741577B1 (en) | The use of interferon subtype alpha 8 in the preparation of medicaments to treat viral infections of the liver | |
EP0299745B1 (en) | Double-stranded RNA correction of RNase L deficiency | |
EP0488718B1 (en) | Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine | |
KR0165674B1 (ko) | 원발성 흉막암의 치료를 위한 제약 조성물 | |
Awisati et al. | The role of interferon-α in the management of myelomatosis | |
JP2008031179A (ja) | β−インターフェロンを使用して再狭窄を治療する方法 | |
KR0168421B1 (ko) | 인간 인터루킨 2 활성을 갖는 폴리펩티드 기재의 항종양제 조성물 | |
CA1291706C (en) | COMBINATION THERAPY USING INTERFERON-.beta. AND INTERLEUKIN-2 | |
EP0687470A2 (en) | Agents for treating metabolic bone diseases | |
Carter et al. | Independent evolution of antiviral and growth-modulating activities of interferon | |
Chapekar et al. | Potentiation of the cytocidal effect of human immune interferon by different synthetic double-stranded RNAs in the refractory human colon carcinoma cell line BE | |
EP1471974B1 (en) | Tumor necrosis factor combined with interferon in demyelinating diseases | |
EP0670165B1 (en) | Use of seminal ribonuclease as antimetastatic compound | |
Fiers et al. | Tumor necrosis factor: a potential antitumor agent? | |
KR0169975B1 (ko) | 감마 인터페론 활성을 갖는 폴리펩티드를 함유하는 원발성 흉막암 치료용 제약 조성물 | |
Richtsmeier | The interferons | |
EP1285663B1 (en) | Protective interferon-beta against reinfection after liver transplantation | |
KIMOTO et al. | Interferon treatment of human stomach and breast carcinoma xenografts in nude mice | |
Miyake et al. | Synergistic effect of natural human tumor necrosis factors α and β in the clonogenic assay | |
JPS62265233A (ja) | インタ−フエロン−β及びインタ−ロイキン−2を含有する医薬組成物 | |
von Wussow | Intralesional Interferon-Alpha-Therapy in Advanced Malignant Melanoma | |
EP1536825A1 (en) | Interferon and immunoglobulin fc fragment hybrid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
RH | Patent void |